Cytokinetics(CYTK) - 2024 Q2 - Earnings Call Transcript

Cytokinetics, Incorporated (NASDAQ:CYTK) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Diane Weiser - VP, Corporate Affairs Robert Blum - President, CEO Fady Malik - EVP, R&D Chris Murray - SVP, Regulatory Affairs and Quality Andrew Callos - EVP and Chief Commercial Officer Stuart Kupfer - SVP and Chief Medical Officer Sung Lee - EVP and CFO Conference Call Participants Salim Syed - Mizuho Akash Tewari - Jefferies Roanna Ruiz - Leerink Paul Choi - Goldman Sachs Kripa Devara ...